Xarelto Lawsuit Guide

Xarelto, the number one prescribed blood thinner in America, is facing numerous lawsuits after its side effects caused irreversible bleedings, stroke, and death. Xarelto has been classified as one of the most dangerous drugs available on the market by the Institute for Safe Medication Practices (ISMP). Approved by the Food and Drugs Administration (FDA), this drug has injured thousands and caused fatal bleeding accidents.

To date, the number of Xarelto lawsuits passed the mark of 16,000 cases filed in court. Roughly 15,600 federal lawsuits have been consolidated in a Multi-District Litigation in Louisiana, while another 550 have been grouped in a class-action that will be held in a Pennsylvania court.

Please seek the advice of a healthcare provider before discontinuing the use of this medication

Bellwether Trial Date:        April 2017

Injury: Bleeding Accidents, stroke, and death.

Cases Filled:  18,000

Settlement Amounts: EST – $100,000 over $1,000,000

Plaintiffs’ principal Lawsuit accusations

Since Xarelto (rivaroxaban) received approval in 2011, Bayer AG and Janssen Pharmaceuticals (a Johnson & Johnson’s subsidiary) made millions by selling this Novel Oral Anticoagulant (NOAC) to US patients. This blood thinner is used to prevent blood clots and strokes in people who suffer from Atrial Fibrillation (Afib), Pulmonary Embolism (PE), and Deep Vein Thrombosis (DVT). However, this drug is also very dangerous, as it may cause uncontrollable bleedings that cannot be stopped since there is no antidote available to reverse its effects. Many people who were injured by the Xarelto side effects filed a litigation against the manufacture pharmaceutical companies Bayer, Johnson & Johnsons and Janssen Pharmaceuticals, holding them accountable for the harm they suffered. Both Bayer and J&J, in fact, never warned patients properly about the medication’s risks.

Plaintiffs’ principal accusations include negligence and failure to warn since the absence of a strong warning label about its complications prevented doctors from adequately understanding the real dangers associated with this drug. Patients who switched from older (and allegedly safer) anticoagulant drugs to this one, should now be scared even by the mildest trauma since just a simple bump or fall may cause a potentially fatal bleeding. According to the many claims, the pharmaceutical companies only focused on the drug’s safety and benefits, and never thoroughly explained its potential hazards, including the lack of a proper reversal agent.

Understand the Xarelto Trial

Free Xarelto Attorney Consultation

No Fees Unless You Win

Why is Xarelto Considered Dangerous?

One of the most bothering inconveniences of taking old-generation blood thinners such as Warfarin was the necessity of adopting a weekly blood test routine. Together with the annoying dietary restrictions, and the constant dosage adjustment required, Warfarin therapy proved to be burdensome and downright annoying for many people. That was the same reason rivaroxaban became an incredibly successful product in such a short time. In fact, Bayer chose to market Xarelto as the first oral anticoagulant not to require monitoring.

However, the same characteristics that make rivaroxaban more appealing to patients make it also more dangerous to their health. This blood thinner has a very low therapeutic index, meaning that its safe dosage is dangerously close to the one where the drug starts becoming toxic. Even a small shift in those biological activities that flush medications out of our systems may lead to a potentially harmful (or even lethal) overdose. For this same reason, Warfarin required constant monitoring in the first place, as blood testings were the primary instrument through which doctors kept their patients’ health checked. And since no proper antidote exists to reverse the effects of Xarelto, even the smallest bleeding event can become lethal. Unlike Warfarin, for which the administration of Vitamin K is sufficient to stop the hemorrhage, doctor’s have no reliable strategy to save a patient’s life whenever this happens.

Xarelto can cause gastrointestinal bleeding, stroke and wound infections

Xarelto Bleeding events are probably the most publicized reasons to file for compensation since this adverse side effect can usually lead to death.

Gastrointestinal Bleeding is, however, an extremely common form of hidden bleeding caused by this dangerous blood thinner. GI bleeding has been found to be frequent in the elderly patients and those who are currently under treatment with other medications such as nonsteroidal anti-inflammatory drugs (NSAIDs). It includes hemorrhages of the stomach, small intestine, colon, rectum, esophagus and anus (hemorrhoids). Several gastrointestinal bleeding lawsuits have been filed over the course of the last two years, so if your stomach hurts when you’re taking Xarelto, maybe that’s a warning symptom you should not overlook.

Rivaroxaban is also linked to several other severe adverse reactions, including a higher occurrence of infections in surgical wounds after hip or knee replacements interventions. The risk for infection and wound leakage is four-fold higher when a patient is taking this drug. This kind of complications often forces patients to get back to the operating room to receive additional surgery. There are many other equally effective options available for patients to prevent blood clots from forming in the lower limbs after a joint replacements surgery, including other medication such as heparins or aspirin.

Among the various types of bleedings associated with rivaroxaban, brain bleeding (which is a type of stroke) is one of the most dangerous. Medical literature only described a single intracranial hemorrhage case study of a patient who used Xarelto, but brain bleeding is still one of the principal risks listed in this medication label. However, due to the absence of a proper antidote to reverse the anticoagulant’s action, once the adverse reaction starts doctors have no way to stop it. A cerebral bleeding may require hours to subside and may cause a fatal stroke. While physicians wait for the medication to be flushed out from the subject’s body, the damage caused could be permanent or even fatal.

Xarelto’s biggest selling points were its unique one-size-fits-all dosage, as well as the freedom it left patients from enduring any monitoring routines and dietary restrictions. Since 2013, many popular commercials hyped this medication’s superiority over its competitors.

The blood thinner was widely advertised by famous celebrities such as the comedian Kevin Nealon, race car driver Brian Vickers, and golf champion Arnold Palmer. During the commercial, Nealon’s punchline focused around inviting patients to choose whether they would prefer spending their days in a blood clinic checking for their drug’s dosage rather than relaxing in a beautiful golf course.

However, many plaintiffs and their lawyers alleged that the drugmaker simply overstated its safety and effectiveness caring only to increase the profits. Telling the public that no regular blood test monitoring is needed may expose them to unnecessary dangers.

Xarelto Trials Consolidated (MDL Number 2592)

The number of federal lawsuits filed kept steadily growing year after year. Due to the high number of Xarelto litigations that have been filed, the U.S. Judicial Panel on Multidistrict Litigation consolidated these cases into a multidistrict litigation (MDL Number 2592) in the United States District Court for the Eastern District of Louisiana presided over by Judge Eldon Fallon, and a mass tort class action in Philadelphia, Pennsylvania.

An MDL is used to speed up the legal procedures by consolidating many cases into a single one, choosing some of them as the most representative ones (in this case, four cases have been selected). If your dispute becomes a part of an MDL, you will still keep your own lawyer, and your case will be handled as an individual one.

Xarelto Litigation Cases Pending

McGowan v. Janssen

Thomas Dunkley was the first Xarelto victim who died after suffering from a severe bleeding to the brain. Ruth McGowan, who filed the lawsuit on behalf of her deceased father, claims that after using the medication for a month to prevent a risk of stroke, Mr. Dunkley quickly fell ill and then died. Doctors were not able to stop the cerebral hemorrhage, and the poor man died in agony shortly after being hospitalized. The plaintiff accuses Bayer and Janssen of not properly testing rivaroxaban before it was distributed to the public and concealing its dangers with a misleading advertisement campaign.

Packard v. Janssen

William Packard’s wife filed a litigation against Xarelto’s manufacturers after her husband passed away unexpectedly because of the side effects of Xarelto. Attorneys states Mr. Packard was prescribed Xarelto for atrial fibrillation and used the anticoagulant for jus six months before suffering a fatal stroke. Skilled physicians desperately tried to save him with cranial surgery, but the bleeding could not be stopped and eventually caused the man’s death. William’s family now seeks financial compensation, and accuses the pharmaceutical company of not adequately warning the public about the dangerous consequences stemming from the absence of an antidote.

Current Status of the Xarelto Product Liability Lawsuit

Recently, Judge Eldon Fallon scheduled the initial bellwether trial dates for next April and May, while the other cases in the Philadelphia mass tort have been postponed to August 2017. Product liability lawyers got little time left to reviewing their cases, and decide whether their clients are entitled to receive financial compensation before they are summoned to court. Due to the statute of limitations, all lawsuits against Bayer and Janssen not brought in time will be barred, so it’s imperative to file your dispute as soon as possible before time runs out. As per April 2017, JPML’s latest records report a total of 16,285 cases currently pending in the MDL, defining the mass tort as one of the biggest in the history of pharmaceutical liability litigations.

Page Sources and References